Pneumococcal Conjugate Vaccine in Aging Renal Transplant

NCT03802994 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

TERMINATED

Status

57

Enrollment

FED

Sponsor class

Stopped Due to COVID pandemic further recruitment of subjects was unethical.

Conditions

Renal Transplantation
Aging

Interventions

DRUG: 23 valent pneumococcal polysaccharide vaccine
BIOLOGICAL: 13 valent conjugated pneumococcal vaccine
OTHER: Peripheral blood sample

Sponsor

VA Office of Research and Development